The Board of Directors of the Company in its meeting held on Tuesday, 11th November, 2025 has considered and approved the following business:- 1. The Consolidated and Standalone Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250 and 5.1 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
TCM Limited's board approved its unaudited Q2 and H1 FY26 results. Standalone revenue from operations fell to ₹501.51 lakhs in Q2 FY26 from ₹648.95 lakhs in Q2 FY25, a ~23% YoY decline, while H1 revenue dropped ~30% to ₹806.38 lakhs. The company reported a standalone loss before tax of ₹31.30 lakhs in Q2 (vs ₹18.68 lakhs loss in Q2 FY25) and ₹182.94 lakhs in H1 FY26 (vs ₹62.93 lakhs loss in H1 FY25), with H1 EPS at ₹(2.40). On a consolidated basis, Q2 revenue declined to ₹592.07 lakhs and H1 loss widened to ₹318.42 lakhs, dragged by losses in the Educational and Trading segments. The auditor (S G M & Associates LLP) issued an unmodified limited review report with no qualifications or emphasis of matter. Operating cash flow was deeply negative at ₹(537) lakhs standalone, prompting ₹750 lakhs in new long-term borrowings; cash balance stands at just ₹1.72 lakhs. The company also disclosed an advance of ₹102.56 lakhs towards acquiring 100% of Better Feeds Private Limited for a total consideration of ₹765 lakhs.
Shareholders should note widening losses, declining revenues, and negative operating cash flow requiring fresh borrowings, suggesting continued stress in core operations. The proposed acquisition of Better Feeds may signal a strategic pivot, but execution risk is high given the weak financial position and very low cash buffer.